Cover Image
市場調查報告書

全球幹細胞市場:各國 (美國、加拿大、印度、中國、日本、英國)、企業簡介、佔有率、趨勢、分析、機會、市場區隔及2015∼2021年的預測

Global Stem Cells Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 348575
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球幹細胞市場:各國 (美國、加拿大、印度、中國、日本、英國)、企業簡介、佔有率、趨勢、分析、機會、市場區隔及2015∼2021年的預測 Global Stem Cells Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022
出版日期: 2016年04月25日 內容資訊: 英文 140 Pages
簡介

全球幹細胞市場2015∼2021年,預計以年複合成長率23%擴大。癌症和癌症相關疾病的罹患率,由於發病率的上升等各式各樣的因素。研究開發計劃的增加和擴大生物標誌物的使用,切片檢查市場成長等也成為促進該市場的原因之一。

本報告提供與全球幹細胞市場相關調查、市場趨勢以及到2021年的收益預測成長率、產業趨勢、競爭、各國趨勢,加上進入的主要企業的簡介等彙整。

第1章 簡介

第2章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 指標分析
  • 市場趨勢
  • 競爭情報
  • 價值鏈分析
  • 主要的購買標準
  • 策略性建議
  • 策略性結論

第3章 市場決策因素

  • 促進要素
    • 癌症及癌症相關疾病的罹患率高
    • 幹細胞銀行的增加
    • 政府的幹細胞研究的投資擴大
    • 兒童的癌症發病率上升
  • 阻礙要素
    • 幹細胞治療高
    • 新興市場被都市區限定
  • 課題
    • 認證流程晚
    • 專利侵害
  • 機會
    • 醫療觀光
    • 新興市場上意識提升

第4章 部門分析

第5章 市場區隔

  • 各產品全球幹細胞市場:2014∼2021年
  • 各用途市場
  • 各科技市場

第6章 競爭環境

  • 市場佔有率
  • 策略

第7章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第8章 企業簡介

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HBI-1341015

The global stem cells market is driven by various factors which includes increasing prevalence and incidence rate of cancer and cancer related diseases. Rising research and development programs, increasing awareness related to regenerative treatment, increasing use of biomarkers and growth in biopsy market are also driving the market. High prevalence of cancer in children is also a key driving factor for stem cell study. The number of stem cell banks has increased exponentially. Number of hospitals and research centres in developed countries are capable of storing stem cells. Even in countries such as China and India, the growing awareness amongst the professionals and masses is key driver for the market. India, China and other emerging nations are also offering stem cell therapies and services and lower cost which is leading to emergence of medical tourism in stem cells market.

The market is segmented on the basis of product type, applications and by technology. The product types consist of adult stem cells, human embryonic stem cells market, induced pluripotent stem cells market and very small embryonic like cells market. Applications include regenerative medicines market which is further segmented as cancer regenerative medicines market, orthopaedics regenerative medicines market, haematological regenerative medicines market, neurological regenerative medicines market, cardiovascular regenerative medicines market, regenerative medicines market, injuries regenerative medicines market and others regenerative medicines market. Drug discovery is also a major application. Stem cells market by technology includes bone marrow harvest, apheresis, umbilical blood cord, therapeutic cloning, in vitro fertilization, isolation, cell culture, cryopreservation, and expansion and sub culture.

Geographically, the market is segment as North America, Europe, Asia Pacific and rest of the world. North America has the highest market share followed by Europe and Asia Pacific. Asia Pacific is expected to report highest growth rate for the forecasted period. Key companies in the market includes STEMCELL technologies, Millipore, Corning, BioTime Inc, Advanced Cell technology Inc, Cellular engineering technologies and other major companies.

Company profiles

  • 1. STEMCELL technologies
  • 2. Millipore
  • 3. Corning
  • 4. BioTime Inc
  • 5. Advanced Cell technology Inc
  • 6. Cellular engineering technologies
  • 7. Cellartis AB
  • 8. Angel Biotechnology
  • 9. Bioheart Inc
  • 10. Cellgene corporation
  • 11. Brainstorm cell therapeutics
  • 12. Osiris therapeutics
  • 13. BD biosciences
  • 14. Lonza
  • 15. ATCC
  • 16. Allcells
  • 17. Miltenyi biotec GmBH
  • 18. QIAGEN
  • 19. Novocell
  • 20. Stemgent
  • 21. Sigma Aldrich
  • 22. Invitrogen
  • 23. Nunc
  • 24. Peprotec
  • 25. R&D systems
  • 26. Cellular dynamics international
  • 27. ChanTest corporation
  • 28. Wiicell research institute
  • 29. Hybrid Organ GmBH
  • 30. BIOE
  • 31. Aastrom Biosciences
  • 32. California Stem Cells
  • 33. International Stem Cell Corporation
  • 34. NeoStem
  • 35. NeuralStem
  • 36. Medistem
  • 37. Apceth
  • 38. Cardio3 BioSciences
  • 39. TiGenix

This Occams Research Report covers

  • 1. Historical data
  • 2. Revenue forecasts, growth rates and CAGR up to 2021
  • 3. Industry Analysis
  • 4. Competitive Analysis
  • 5. Key geographic growth data

Table of Contents

1. Introduction

  • 1.1. Executive summary
  • 1.2. Estimation methodology

2. Market overview

  • 2.1. Market definition and scope
  • 2.2. Key findings
  • 2.3. Parametric analysis
    • 2.3.1. Healthcare expenditure across geographies
    • 2.3.2. Disposable income of top emerging economies
  • 2.4. Key market insights
    • 2.4.1. Top 3 emerging countries
    • 2.4.2. Top 3 revenue generating segments
    • 2.4.3. Top growing markets and emerging trends
    • 2.4.4. R&D scenario
    • 2.4.5. Pricing analysis
  • 2.5. Competitive intelligence
    • 2.5.1. Market share analysis
    • 2.5.2. Top winning strategies
    • 2.5.3. Case studies: Top competitive moves
  • 2.6. Value Chain analysis
  • 2.7. Key buying criteria
  • 2.8. Strategic recommendation
  • 2.9. Strategic conclusions

3. Market determinants

  • 3.1. Market drivers
    • 3.1.1. High prevalence of cancer and cancer related diseases
    • 3.1.2. Growing number of stem cell banks
    • 3.1.3. High investment in stem cell research by government
    • 3.1.4. Growing incidence of cancer in children.
  • 3.2. Market Restraints
    • 3.2.1. High cost of stem cell therapies
    • 3.2.2. The market in emerging countries is confined to urban areas
  • 3.3. Market challenges
    • 3.3.1. Slow process of approval
    • 3.3.2. Patent infringements
  • 3.4. Market opportunities
    • 3.4.1. Medical tourism
    • 3.4.2. Growing awareness in emerging markets

4. Sector Analysis

  • 4.1. Parent market
  • 4.2. Sub-segment market
  • 4.3. Alternative market

5. Market Segmentation

  • 5.1. Global market stem cell market by product type 2014-2021 ($ million)
    • 5.1.1. Global adult stem cells market 2014-2021 ($ million)
      • 5.1.1.1. Global hematopoietic stem cells market 2014-2021 ($ million)
      • 5.1.1.2. Global mesenchymal stem cells market 2014-2021 ($ million)
      • 5.1.1.3. Global neuronal stem cells market 2014-2021 ($ million)
      • 5.1.1.4. Global dental stem cells market 2014-2021 ($ million)
      • 5.1.1.5. Global umbilical cord stem cells market 2014-2021 ($ million)
    • 5.1.2. Global human embryonic stem cells market 2014-2021 ($ million)
    • 5.1.3. Global induced pluripotent stem cells market 2014-2021 ($ million)
    • 5.1.4. Global very small embryonic like cells market 2014-2021 ($ million)
  • 5.2. Global stem cells market by application 2014-2021 ($ million)
    • 5.2.1. Global regenerative medicines market 2014-2021 ($ million)
      • 5.2.1.1. Global cancer regenerative medicines market 2014-2021 ($ million)
      • 5.2.1.2. Global orthopedics regenerative medicines market 2014-2021 ($ million)
      • 5.2.1.3. Global hematological regenerative medicines market 2014-2021 ($ million)
      • 5.2.1.4. Global neurological regenerative medicines market 2014-2021 ($ million)
      • 5.2.1.5. Global cardiovascular regenerative medicines market 2014-2021 ($ million)
      • 5.2.1.6. Global regenerative medicines market 2014-2021 ($ million)
      • 5.2.1.7. Global injuries regenerative medicines market 2014-2021 ($ million)
      • 5.2.1.8. Global others regenerative medicines market 2014-2021 ($ million)
    • 5.2.2. Global stem cells in drug discovery market 2014-2021 ($ million)
  • 5.3. Global stem cells market by technology 2014-2021 ($ million)
    • 5.3.1. Global bone marrow harvest market 2014-2021 ($ million)
    • 5.3.2. Global apheresis market 2014-2021 ($ million)
    • 5.3.3. Global umbilical blood cord market 2014-2021 ($ million)
    • 5.3.4. Global therapeutic cloning market 2014-2021 ($ million)
    • 5.3.5. Global in vitro fertilization market 2014-2021 ($ million)
    • 5.3.6. Global isolation market 2014-2021 ($ million)
    • 5.3.7. Global cell culture market 2014-2021 ($ million)
    • 5.3.8. Global cryopreservation market 2014-2021 ($ million)
    • 5.3.9. Global expansion and sub culture market 2014-2021 ($ million)

6. Competitive Landscape

  • 6.1. Market share
  • 6.2. Strategy - An analysis across tiers

7. Geographical analysis

  • 7.1. North America stem cells market ($ million)
    • 7.1.1. United States (US) stem cells market ($ million)
    • 7.1.2. Canada stem cells market ($ million)
  • 7.2. Europe stem cells market ($ million)
    • 7.2.1. United Kingdom (UK) stem cells market ($ million)
    • 7.2.2. France stem cells market ($ million)
    • 7.2.3. Germany stem cells market ($ million)
    • 7.2.4. Spain stem cells market ($ million)
    • 7.2.5. Italy stem cells market ($ million)
    • 7.2.6. Roe stem cells market ($ million)
  • 7.3. Asia Pacific stem cells market ($ million)
    • 7.3.1. India stem cells market ($ million)
    • 7.3.2. China stem cells market ($ million)
    • 7.3.3. Japan stem cells market ($ million)
    • 7.3.4. Korea stem cells market ($ million)
    • 7.3.5. Australia stem cells market ($ million)
    • 7.3.6. RoAPAC stem cells market ($ million)
  • 7.4. Rest of the world stem cells market ($ million)
    • 7.4.1. Latin America stem cells market ($ million)
    • 7.4.2. MENA stem cells market ($ million)
    • 7.4.3. Africa stem cells market ($ million)

8. Company Profiles:

  • 8.1. STEMCELL technologies
  • 8.2. Millipore
  • 8.3. Corning
  • 8.4. Biotime Inc
  • 8.5. Advanced Cell technology Inc
  • 8.6. Cellular engineering technologies
  • 8.7. Cellartis AB
  • 8.8. Angel Biotechnology
  • 8.9. Bioheart Inc
  • 8.10. Cellgene corporation
  • 8.11. Brainstorm cell therapeutics
  • 8.12. Osiris therapeutics
  • 8.13. BD biosciences
  • 8.14. Lonza
  • 8.15. ATCC
  • 8.16. Allcells
  • 8.17. Miltenyi biotec gmbh
  • 8.18. QIAGEN
  • 8.19. Novocell
  • 8.20. Stemgent
  • 8.21. Sigma Aldrich
  • 8.22. Invitrogen
  • 8.23. Nunc
  • 8.24. Peprotec
  • 8.25. R&D systems
  • 8.26. Cellular dynamics international
  • 8.27. Chantest corporation
  • 8.28. Wiicell research institute
  • 8.29. Hybrid Organ gmbh
  • 8.30. BIOE
  • 8.31. Aastrom Biosciences
  • 8.32. California Stem Cells
  • 8.33. International Stem Cell Corporation
  • 8.34. Neostem
  • 8.35. Neuralstem
  • 8.36. Medistem
  • 8.37. Apceth
  • 8.38. Cardio3 biosciences
  • 8.39. Tigenix
Back to Top